Stocks
IGM Biosciences (IGMS) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 4.99 | 4.25 | 1.21 | 1.69 | 1.17 | 1.01 | ||
| Changes by years, y/y, % | -3 675% | -15% | -71% | +39% | -31% | |||
IGM Biosciences. Debt/EBITDA
IGM Biosciences. Debt/EBITDA, changes, %
IGM Biosciences (IGMS) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 1.41 | 1.42 | 1.38 | 1.16 | 1.01 | 1.01 | ||
| Changes by years, y/y, % | +62% | -41% | -32% | -33% | -28% | |||
| Changes by quarters, q/q, % | -18% | +0% | -3% | -16% | -12% | |||
